NYSE / NASDAQ · SEC EDGAR
Equity research
Start with company fundamentals. Compare growth and capital returns, then narrow the research to the companies that meet your criteria.
Research preview · Quarterly financial statements · No price quotes · Not financial advice
Example screens
- Best combined rank222Issuers with both EPS acceleration and ROE, highest rank first.
- Profitable growth43ROE at least 15% and revenue growth at least 10%.
- Earnings acceleration376EPS acceleration at or above zero, largest first.
- High return on equity120ROE at least 25%, highest first.
- NYSE only128The same ranking with NYSE listings only.
Example lists from a senior trader
- All 47 screens9191 of 279 companies are in this screen.
- 2026 · 06-27 14023566 of 8 companies are in this screen.
- 2026 · 06-27 14000344 of 10 companies are in this screen.
- 2026 · 06-27 14012944 of 9 companies are in this screen.
- 2026 · 06-27 14014744 of 9 companies are in this screen.
- 2026 · 06-27 14015833 of 9 companies are in this screen.
- 2026 · 06-27 14022744 of 9 companies are in this screen.
- 2026 · 06-27 14031844 of 10 companies are in this screen.
- 2026 · 06-27 14081955 of 8 companies are in this screen.
| Company | Combined rank | EPS acceleration | Revenue growth | ROE | Net margin | Reporting period |
|---|---|---|---|---|---|---|
| CTNMContineum Therapeutics, Inc.NASDAQ | — | — | — | -24.0% | — | 2026-06-30Filed 2026-07-30 |
| CTNTCHEETAH NET SUPPLY CHAIN SERVICE INC.NASDAQ | — | — | 145.4% | -3.6% | -206.8% | 2026-06-30Filed 2026-08-13 |
| CTOCTO Realty Growth, Inc.NYSE | — | — | 15.0% | 2.4% | 9.1% | 2026-03-31Filed 2026-04-28 |
| CTORCITIUS ONCOLOGY, INC.NASDAQ | — | — | — | -114.1% | — | 2026-06-30Filed 2026-08-14 |
| CTOSCustom Truck One Source, Inc.NYSE | — | — | 6.5% | 2.6% | 1.4% | 2026-06-30Filed 2026-08-03 |
| CTRICenturi Holdings, Inc.NYSE | — | — | 32.9% | 3.3% | 0.9% | 2026-06-28Filed 2026-08-04 |
| CTRNCiti Trends IncNASDAQ | — | -851.2 pp | 10.9% | — | — | 2026-08-01Filed 2026-09-09 |
| CTSCTS CORPNYSE | — | — | 10.7% | 12.4% | 12.5% | 2026-03-31Filed 2026-04-29 |
| CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORPNASDAQ | — | — | 5.8% | 14.8% | 10.4% | 2026-03-31Filed 2026-04-29 |
| CTSOCytosorbents CorpNASDAQ | — | — | 0.2% | — | — | 2026-06-30Filed 2026-08-06 |
| CTWOCOTWO ADVISORS PHYSICAL EUROPEAN CARBON ALLOWANCE TRUSTNYSE | — | — | — | — | — | 2026-05-31Filed 2026-07-06 |
| CTXRCitius Pharmaceuticals, Inc.NASDAQ | — | — | — | — | — | 2026-06-30Filed 2026-08-14 |
| CUBLionheart HoldingsNASDAQ | — | — | — | — | — | 2026-06-30Filed 2026-08-14 |
| CUBECubeSmartNYSE | — | — | 3.3% | — | — | 2026-03-31Filed 2026-05-01 |
| CUECue Biopharma, Inc.NASDAQ | — | — | 166.7% | -7104.2% | -435.8% | 2026-06-30Filed 2026-08-14 |
| CULPCULP INCNASDAQ | — | — | 6.5% | — | — | 2026-08-02Filed 2026-09-11 |
| CURBCurbline Properties Corp.NYSE | — | — | 49.9% | — | — | 2026-03-31Filed 2026-04-29 |
| CURVTorrid Holdings Inc.NYSE | — | 250.0 pp | -11.8% | — | -0.9% | 2026-08-01Filed 2026-09-10 |
| CURXCuranex Pharmaceuticals IncNASDAQ | — | — | — | -218.7% | — | 2026-06-30Filed 2026-08-14 |
| CVCapsoVision, IncNASDAQ | — | — | 9.9% | -226.6% | -214.7% | 2026-06-30Filed 2026-08-13 |
| CVCOCAVCO INDUSTRIES, INC.NASDAQ | — | — | 9.5% | 16.3% | 7.9% | 2026-06-27Filed 2026-07-31 |
| CVEOCiveo CorpNYSE | — | — | 10.6% | -8.3% | -1.9% | 2026-06-30Filed 2026-07-30 |
| CVGICommercial Vehicle Group, Inc.NASDAQ | — | — | 13.5% | -16.9% | -3.4% | 2026-06-30Filed 2026-08-03 |
| CVICVR ENERGY INCNYSE | — | — | 55.5% | 13.1% | 0.8% | 2026-06-30Filed 2026-07-29 |
| CVKDCadrenal Therapeutics, Inc.NASDAQ | — | — | — | -282.1% | — | 2026-06-30Filed 2026-08-13 |
How the lists overlap
EPS acceleration is the change in year-over-year quarterly EPS growth, expressed in percentage points. Revenue growth compares matching quarters a year apart. ROE divides four consecutive quarters of net income by equity at the same latest reporting date.
The combined rank averages the EPS acceleration and ROE percentiles among issuers with both metrics. It ranges from 0 to 100 and describes relative position within this covered group. It is not a probability or a performance estimate.
Net margin uses four consecutive quarters with matching revenue and net income. Missing quarters stay unavailable; additive fourth-quarter values may be derived from annual minus nine-month totals known at the filing date. EPS is never derived this way.
What this data covers
Source: SEC EDGAR company facts. Each value must have been filed on or before the displayed as-of date. Reporting periods older than 185 days are excluded.
The current exchange universe includes multiple security types. The screen shows one ticker per issuer with supported US-GAAP facts; it is not a complete historical stock universe. Missing companies and ratios are coverage gaps, not negative assessments.
Snapshots update daily. Close-price series are shown for the companies the BibaMoney price store covers — the coverage line above states how many of the current matches that is, and a card without a series says so instead of drawing a line. Sector metadata and validated price outcomes are not included: no price outcome in this screen has been checked out of sample.
Macro context: the 10Y–3M Treasury curve was non-inverted on 2026-09-18. Source: FRED / Federal Reserve.